Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patients
Pipettes are seen at the Moderna Therapeutics Inc. lab in Cambridge, Massachusetts, U.S., on Tuesday, Nov. 14, 2017. Moderna this week started testingAdam Glanzman | Bloomberg | Getty ImagesModerna and Merck will jointly develop and sell…